PERSONALISIERTE HERZRHYTHMUSTHERAPIE

European patent · EP4312769 · In force

Register entry

Publication number
EP4312769
Application number
EP22720506
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 15, 2022
Published
Feb 7, 2024
Granted
Apr 9, 2025
Protection ends at the latest
Apr 14, 2042
Next annual fee due
Apr 30, 2027
IPC classes
A61B 5/282 (2021.01)
A61B 5/287 (2021.01)
A61B 5/367 (2021.01)
A61B 5/00 (2006.01)
A61B 18/14 (2006.01)
Priority
US 202163175986 P 16.04.2021
PCT application
PCT/IB2022/053574 15.04.2022
PCT publication
WO2022/219604 20.10.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. Feb 18, 2026

    Change

    Published in Swissreg on 18.02.2026

  3. Aug 6, 2025

    Owner

    Owner
    Physcade, Inc., 3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA 94306, USA → Physcade, Inc., 2100 Geng Rd, Suite 210, Palo Alto, CA 94303, USA

    Published in Swissreg on 06.08.2025

  4. Jun 17, 2025

    Change

    Published in Swissreg on 17.06.2025

  5. Apr 9, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.04.2025

Parties

Holder

Physcade, Inc.

2100 Geng Rd, Suite 210, Palo Alto, CA 94303, US

Inventor

RODRIGO BORT, Miguel

Palo Alto, California 94306, US

ALHUSSEINI, Mahmood I.

Palo Alto, California 94306, US

NARAYAN, Sanjiv M.

Palo Alto, California 94306, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.